Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Accumulated Expenses (2018 - 2023)

Select Medical Holdings (SEM) has disclosed Accumulated Expenses for 6 consecutive years, with $32.5 million as the latest value for Q4 2023.

  • For Q4 2023, Accumulated Expenses fell 78.45% year-over-year to $32.5 million; the TTM value through Dec 2023 reached $32.5 million, down 78.45%, while the annual FY2023 figure was $32.5 million, 78.45% down from the prior year.
  • Accumulated Expenses hit $32.5 million in Q4 2023 for Select Medical Holdings, up from $12.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $152.3 million in Q2 2022 and bottomed at $9.9 million in Q1 2022.
  • Average Accumulated Expenses over 5 years is $60.0 million, with a median of $29.6 million recorded in 2020.
  • On a YoY basis, Accumulated Expenses climbed as much as 426.23% in 2022 and fell as far as 92.63% in 2022.
  • Select Medical Holdings' Accumulated Expenses stood at $33.9 million in 2019, then fell by 13.63% to $29.2 million in 2020, then surged by 392.64% to $144.0 million in 2021, then rose by 4.61% to $150.7 million in 2022, then plummeted by 78.45% to $32.5 million in 2023.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $32.5 million, $12.0 million, and $29.5 million for Q4 2023, Q3 2023, and Q2 2023 respectively.